AUR-105

N/A

Report date: 2026/04/18 20:00:19
NME

Base Information

Drug NameAUR-105
Drug Alias NameAUR-105
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein arginine methyltransferase 5 inhibitors
TargetsProtein arginine methyltransferase 5
Therapy Area/IndicationsSolid tumoursLymphoma, Non-HodgkinHodgkin Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAurigene Discovery Technologies (Malaysia) Sdn Bhd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAurigene Discovery Technologies Ltd
Active IndicationsN/A
Inactive IndicationsSolid tumoursLymphoma, Non-HodgkinHodgkin Disease

Other Information

ATC CodeN/A
Related LinksN/A